Journal of Hepatology
Volume 51, Issue 6 , Pages 1010-1020 , December 2009

The epidermal growth factor receptor ligand amphiregulin is a negative regulator of hepatic acute-phase gene expression

  • Ana Pardo-Saganta

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
    • ,
  • Maria Ujue Latasa

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
    • ,
  • Josefa Castillo

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
    • ,
  • Laura Alvarez-Asiain

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
    • ,
  • María J. Perugorría

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
    • ,
  • Pablo Sarobe

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
    • ,
  • Carlos M. Rodriguez-Ortigosa

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
    • ,
  • Jesús Prieto

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
    • CiberEhd, Clínica Universidad de Navarra, Pamplona, Spain
    • ,
  • Carmen Berasain

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
    • ,
  • Mónica Santamaría

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
    • Corresponding Author InformationCorresponding authors. Tel.: +34 948194700; fax: +34 948194717. (M.A. Avila)
    • ,
  • Matías A. Avila

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
    • Corresponding Author InformationCorresponding authors. Tel.: +34 948194700; fax: +34 948194717. (M.A. Avila)

Received 16 April 2009 ,Revised 9 June 2009 ,Accepted 25 June 2009.

References 

  1. Baumann H, Gauldie J. The acute phase response. Immunol Today. 1994;15:74–80
  2. Gabay CG, Kushner I. Acute-phase proteins and other systemic responses to inflammation. New Engl J Med. 1999;340:448–454
  3. Moshage H. Cytokines and the hepatic acute phase response. J Pathol. 1997;181:257–266
  4. Streetz KL, Wüstefeld T, Klein C, Manns MP, Trautwein C. Mediators of inflammation and acute phase response in the liver. Cell Mol Biol (Noysi-le-grand). 2001;47:661–673
  5. Poli V. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem. 1998;273:29279–29282
  6. Alonzi T, Maritano D, Gorgoni B, Rizzuto G, Libert C, Poli V. Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene activation in the liver. Mol Cell Biol. 2001;21:1621–1632
  7. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J. 2003;374:1–20
  8. Tanaka M, Miyajima A, Oncostatin M. A multifunctional cytokine. Rev Physiol Biochem Pharmacol. 2003;149:39–52
  9. Kordula T, Rydel RE, Brigham EF, Horn F, Heinrich PC, Travis J. Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate α1-antichymotrypsin expression in human cortical astrocytes. J Biol Chem. 1998;273:4112–4118
  10. Kim H, Baumann H. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells. Mol Cell Biol. 1999;19:5326–5338
  11. Kino T, Rice KC, Chrousos GP. The PPARδ agonist GW501516 suppresses interleukin-6-mediated hepatocyte acute phase reaction via STAT3 inhibition. Eur J Clin Invest. 2007;37:425–433
  12. Milland J, Tsykin A, Thomas T, Aldred AR, Cole T, Schreiber G. Gene expression in regenerating and acute-phase rat liver. Am J Physiol Gastrointest Liver Physiol. 1990;259:G340–G347
  13. Scotté M, Masson S, Lyoumi S, Hiron M, Ténière P, Lebreton JP, et al. Cytokine gene expression in liver following minor or major hepatectomy. Cytokine. 1997;9:859–867
  14. Kimura F, Miyazaki M, Suwa T, Kaizaki S, Itoh H, Kaiho T, et al. Increased serum interleukin-6 level and reduction of hepatic acute-phase response after major hepatectomy. Eur Surg Res. 1996;28:96–103
  15. Bernuau D, Rogier E, Moreau A, Bernuau J, Feldmann G. Inhibitory effect of the acute inflammatory reaction on liver regeneration after partial hepatectomy in the rat. Gastroenterology. 1986;90:268–273
  16. Dierssen U, Beraza N, Lutz HH, Liedtke C, Ernst M, Wasmuth HE, et al. Molecular dissection of gp130-dependent pathways in hepatocytes during liver regeneration. J Biol Chem. 2008;283:9886–9895
  17. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology. 2006;43:S45–S53
  18. Michalopoulos GK. Liver regeneration. J Cell Physiol. 2007;213:286–300
  19. Guillén MI, Gómez-Lechón MJ, Nakamura T, Castell JV. The hepatocyte growth factor regulates the synthesis of acute-phase proteins in human hepatocytes: divergent effect on interleukin-6-stimulated genes. Hepatology. 1996;23:1345–1352
  20. Bereta J, Szuba K, Fiers W, Gauldie J, Koj A. Transforming growth factor-beta and epidermal growth factor modulate basal and interleukin-6 induced amino acid uptake and acute phase protein synthesis in cultured rat hepatocytes. FEBS Lett. 1990;266:48–50
  21. Wang Y, Ripperger J, Fey GH, Samols D, Kordula T, Wetzler M, et al. Modulation of hepatic acute phase gene expression by epidermal growth factor and src protein tyrosine kinases in murine and human hepatic cells. Hepatology. 1999;30:682–697
  22. Berasain C, Castillo J, Prieto J, Avila MA. New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system. Liver Int. 2007;27:174–185
  23. Berasain C, García-Trevijano ER, Castillo J, Erroba E, Lee DC, Prieto J, et al. Amphiregulin: an early trigger for liver regeneration in mice. Gastroenterology. 2005;128:424–432
  24. Berasain C, García-Trevijano ER, Castillo J, Erroba E, Santamaría M, Lee DC, et al. Novel role for amphiregulin in protection from liver injury. J Biol Chem. 2005;280:19012–19020
  25. Castillo J, Erroba E, Perugorría MJ, Santamaría M, Lee DC, Prieto J, et al. Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells. Cancer Res. 2006;66:6129–6138
  26. Wu JC, Merlino G, Fausto N. Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor α. Proc Natl Acad Sci USA. 1994;91:674–678
  27. Gschwind A, Hart S, Fischer OM, Ullrich A. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J. 2003;22:2411–2421
  28. Fattori E, Cappelletti M, Costa P, Sellitto C, Cantoni L, Carelli M, et al. Defective inflammatory response in interleukin 6-deficient mice. J Exp Med. 1994;180:1243–1250
  29. Desbois-Mouthon C, Cacheux W, Blivet-Van Eggelpoël MJ, Barvu V, Fartoux L, Poupon R, et al. Impact of IGF-1R/EGFR cross-talks on hepatoma cell sensitivity to gefitinib. Int J Cancer. 2006;119:2557–2566
  30. Richards CD, Brown TJ, Shoyab M, Baumann H, Gauldie J. Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cell and rat primary hepatocytes in vitro. J Immunol. 1992;148:1731–1736
  31. Wang Y, Robledo O, Kinzie E, Blanchard F, Richards C, Miyajima A, et al. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor. J Biol Chem. 2000;275:25273–25285
  32. Stross C, Radtke S, Clahsen T, Gerlach C, Volkmer-Engert R, Schaper F, et al. Oncostatin M receptor-mediated signal transduction is negatively regulated by SOCS3 through a receptor tyrosine-independent mechanism. J Biol Chem. 2006;281:8458–8468
  33. Lu W, Gong D, Bar-Sagi D, Cole PA. Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling. Mol Cell. 2001;8:759–769
  34. Andersson CX, Sopasakis VR, Wallerstedt E, Smith U. Insulin antagonizes interleukin-6 signaling and is anti-inflammatory in 3T3–L1 adipocytes. J Biol Chem. 2007;282:9430–9435
  35. Natarajan A, Wagner B, Sibilia M. The EGF receptor is required for efficient liver regeneration. Proc Natl Acad Sci USA. 2007;104:17081–17086
  36. Mitchell C, Nivison M, Jackson LF, Fox R, Lee DC, Campbell JS, et al. Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration. J Biol Chem. 2005;280:2562–2568
  37. Perugorria MJ, Latasa MU, Nicou A, Cartagena-Lirola H, Castillo J, Goñi S, et al. The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis. Hepatology. 2008;48:1251–1261
  38. Quesnelle KM, Boehm AL, Grandis JR. STAT-mediated EGFR signalling in cancer. J Cell Biochem. 2007;102:311–319

☆ The authors who have taken part in this study declared that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript.

PII: S0168-8278(09)00582-0

doi: 10.1016/j.jhep.2009.06.030

Journal of Hepatology
Volume 51, Issue 6 , Pages 1010-1020 , December 2009

Article Tools

* Image Usage & Resolution